This website is intended for healthcare professionals

Aysha Mendes

Freelance journalist, specialising in psychology and healthcare

Email Aysha

Novel application of ozone therapy for current and emerging diseases

In 1929, a book entitled ‘Ozone and its therapeutic actions’ was published, detailing more than 100 diseases that could be treated by O3 therapy (Juchniewicz and Lubkowska, 2020), and our knowledge of...

Past the peak: navigating depression in the aftermath of COVID-19

Depression was already one of the commonest mental disorders in Great Britain, but new research has shown that the COVID-19 pandemic has resulted in an increase of mental distress in adults across the...

Racial disparity and implicit bias in prescribing practice

Donna Kinnair, head of the Royal College of Nursing (herself no stranger to racism as a black woman living in the UK) points out that patients in black and minority communities have the worst outcomes...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

Reframing the way we think about cancer therapy

One such therapy, first offered to patients in the UK in early 2019, is chimeric antigen receptor T-cell (CAR-T). CAR-T forms part of a newer class of medicines called advanced therapy medicinal...

Changing the way pain is perceived

Millions of patients across Britain, as well as their families and carers, are affected by chronic pain. Unfortunately, chronic pain can have a devastating impact upon a person's day-to-day life,...

Opioid prescribing raises concerns

There appear to be high rates of hospital admissions for drug misuse poisoning in areas with high levels of opioid prescription (Burns, 2019). Although local authority spokespeople claim there is no...

Antibiotic awareness and preventing further antimicrobial resistance

The development of antibiotics has been revolutionary for medicine and public health. However, given the resistance that is now building up against them, we are facing one of the most significant and...

Novel research into glucose-lowering drugs for heart failure shows promise

Alongside important lifestyle changes, first-line treatment for heart failure is an angiotensin-converting enzyme (ACE) inhibitor and a beta blocker licensed for heart failure in people with reduced...

Dependence and withdrawal: how to better support patients

The PHE (2019) review was a response to a call from the Minister for public health and primary care in 2017 for PHE to identify the scale, distribution and causes of prescription drug dependence, and...

Action in asthma: the basics and beyond

The basic care in the UK referred to by Asthma UK consists of the prescription and use of preventer, reliever and combination inhalers, as well as tablets, injections, surgery and other novel...

The vaping controversy: evidence remains a smoky affair

The research surrounding the risks of vaping is conflicting, as e-cigarettes contain nicotine, and are addictive and toxic; however, its effects appear less detrimental to a person's health than...

Targeted therapy and personalised prescription for prostate cancer

Precision medicine takes into account individual variability in genes, environment and lifestyle. It is an emerging approach to disease prevention and treatment that is being increasingly considered...

Medical cannabis: prescribing and research developments

The recently published study in the Journal of Psychopharmacology has revealed that although cannabis does have some harmful effects on the areas of the brain involved in processing sensory and...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP